TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/17/24 07:14 | 6/15/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Barer Sol J | L3 | D | M.d | 0 | 0.00 | 0 | 38 | 10 | 409 | D | |||||||||||||||
8/7/23 16:02 | 8/4/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Barer Sol J | L3 | D | M.d | 0 | 0.00 | 0 | 28 | 8 | 372 | D | |||||||||||||||
3/31/23 16:56 | 3/30/23 | NEXI | Neximmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Barer Sol J | MD | D | P | 164 | 0.4103 | 0 | 400 | 11 | 4,102 | D | |||||||||||||||
11/17/22 20:40 | 11/17/22 | NEXI | Neximmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Barer Sol J | MD | D | P.m | 96 | 0.4811 | 0 | 200 | 6 | 3,627 | D | |||||||||||||||
6/16/22 07:32 | 6/14/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Barer Sol J | L3 | D | M.d | 0 | 0.00 | 0 | 26 | 8 | 343 | D | |||||||||||||||
6/2/22 19:41 | 6/2/22 | NEXI | Neximmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Barer Sol J | MD | D | P.m | 226 | 2.26 | 0 | 100 | 3 | 3,442 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |